Consensus CVRx, Inc.

Stocks

CVRX

US1266381052

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-10 EDT			5-day change	1st Jan Change
2.370 ^USD	-0.84%		-56.91%	-66.62%

08-07	Top Midday Decliners	MT
08-07	Piper Sandler Downgrades CVRx to Neutral From Overweight, Adjusts Price Target to $4 From $12	MT

Evolution of the Average Target: CVRx, Inc.

Evolution of the Target Price: CVRx, Inc.

Changes in Analyst Recommendations: CVRx, Inc.

225171ec788baf2ff9dfded15c40.W_YCYo9zusZlxMbE637BHQq3cmOHf-BPU7H-uuqE5z8.bJxoLvkf0aErg4-ChxS4fGHDPxfyJYQeMP-T_JjdvkgEgTc6xwrSpxO-kw~163387a88d01a14a5fcab92d77680d47

Analysts' recommendations: CVRx, Inc.

08-07	Top Midday Decliners	MT
08-07	Piper Sandler Downgrades CVRx to Neutral From Overweight, Adjusts Price Target to $4 From $12	MT
25-05-09	JPMorgan Downgrades CVRx to Underweight From Neutral, Adjusts Price Target to $7 From $15	MT
24-09-10	Cantor Fitzgerald Initiates CVRx at Overweight With $14 Price Target	MT
24-05-01	JPMorgan Downgrades CVRx to Neutral From Overweight, Adjusts Price Target to $13 From $36	MT
24-05-01	William Blair Downgrades CVRx to Market Perform From Outperform	MT
24-01-26	JPMorgan Raises CVRx's Price Target to $36 From $31, Keeps Overweight Rating	MT
24-01-22	Lake Street Adjusts CVRx Price Target to $35 From $32, Maintains Buy Rating	MT
23-12-27	Lake Street Raises CVRx Price Target to $32 From $21, Maintains Buy Rating	MT
23-11-27	Craig Hallum Adjusts CVRx Price Target to $24 From $22, Maintains Buy Rating	MT
23-05-03	Lake Street Adjusts CVRx's Price Target to $18 From $15, Keeps Buy Rating	MT
23-02-10	Piper Sandler Adjusts Price Target on CVRx to $20 From $18.50, Maintains Overweight Rating	MT
23-02-07	Canaccord Genuity Adjusts Price Target on CVRx to $23 From $22, Maintains Buy Rating	MT
23-01-27	JPMorgan Adjusts Price Target on CVRx to $18 From $17, Maintains Overweight Rating	MT
22-11-02	Piper Sandler Adjusts Price Target on CVRx to $14 From $10, Maintains Overweight Rating	MT
22-07-18	Craig Hallum Initiates CVRx at Buy With $15 Price Target	MT
21-07-26	CVRX : Canaccord Genuity Initiates CVRx at Buy Rating With $30 Price Target	MT
21-07-26	CVRX : JPMorgan Starts CVRx at Overweight with $24 Price Target	MT
21-07-26	CVRX : William Blair Initiates Coverage on CVRx With Outperform Rating	MT
21-07-26	CVRX : Piper Sandler Starts CVRx at Overweight With $26 Price Target	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
CVRX, INC.			+149.65%
PENUMBRA, INC.			+11%
GETINGE AB			-0.54%
ASAHI INTECC CO., LTD.			+8.31%
MINIMED GROUP, INC.			+9.56%
APT MEDICAL INC.			+52.1%
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.			+40.74%
NOVOCURE LIMITED			+56.8%
IMPLANTICA AG	-	-	+28.14%
NAKANISHI INC.			+4.33%
Average			+36.01%
Weighted average by Cap.			+17.94%